At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 75 enrolled
Drug / intervention
Advanced Akreos Adapt in one operated eye. +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of a New Aspheric Intraocular Lens. A Prospective, Multi-Center, Comparative Study.
In Brief
A Phase 4 clinical trial evaluating Advanced Akreos Adapt in one operated eye. and Akreos Adapt in fellow operated eye. for Cataract. Completed, enrolled 75 participants.
Detailed Summary
This study evaluates the visual performance and occurrence of posterior capsular opacification after implantation of a new aspherical intraocular lens compared with a control spherical lens of otherwise identical design.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2004
Primary CompletionJan 2008
First PostedNov 2008
TodayJul 2026
First PostedNov 6, 2008
Enrollment StartJan 1, 2004
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 17.7 years ago
Interventions
Advanced Akreos Adapt in one operated eye.device
Cataract surgery to implant the assigned IOL according to randomized schedule.
Akreos Adapt in fellow operated eye.device
Cataract surgery to implant the assigned IOL according to randomized schedule.